Osaic Holdings’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-396
Closed -$2.46K 7666
2024
Q4
$2.46K Hold
396
﹤0.01% 6526
2024
Q3
$3.46K Buy
+396
New +$3.9K ﹤0.01% 6385
2024
Q2
Sell
-4
Closed -$55 7583
2024
Q1
$55 Hold
4
﹤0.01% 7077
2023
Q4
$152 Sell
4
-1
-20% -$20 ﹤0.01% 7075
2023
Q3
$58 Hold
5
﹤0.01% 7267
2023
Q2
$139 Buy
5
+1
+25% +$58 ﹤0.01% 7255
2023
Q1
$425 Sell
4
-1
-20% -$189 ﹤0.01% 7162
2022
Q4
$1K Sell
5
-3
-38% -$1.3K ﹤0.01% 6932
2022
Q3
$4K Buy
8
+3
+60% +$2.61K ﹤0.01% 6512
2022
Q2
$4K Hold
5
﹤0.01% 6621
2022
Q1
$1.37M Sell
5
-4
-44% -$9.48K ﹤0.01% 2277
2021
Q4
$24K Sell
9
-15
-63% -$60K ﹤0.01% 5677
2021
Q3
$110K Buy
24
+18
+300% +$122K ﹤0.01% 4445
2021
Q2
$43K Sell
6
-2
-25% -$13.8K ﹤0.01% 5158
2021
Q1
$57K Buy
8
+6
+300% +$50.3K ﹤0.01% 4790
2020
Q4
$16K Sell
2
-2
-50% -$18K ﹤0.01% 5294
2020
Q3
$37K Buy
4
+2
+100% +$16.4K ﹤0.01% 4524
2020
Q2
$15K Hold
2
﹤0.01% 4972
2020
Q1
$10K Buy
+2
New +$10K ﹤0.01% 5011

Other funds holding RDHL

Osaic Holdings's RDHL Position: Q1 2025 in Review

Osaic Holdings sold out of Redhill Biopharma (RDHL) in Q1 2025, closing a stake of 396 shares — an estimated $2.46K sold.

Osaic Holdings first reported a position in RDHL in Q1 2020 and held it in 19 quarters. The position peaked at $1.37M in Q1 2022. 12 funds tracked by Wall St. Rank hold RDHL as of Q1 2025.

  • Osaic Holdings reported no remaining Redhill Biopharma position as of Q1 2025 after selling out during the quarter.
  • Osaic Holdings sold 396 Redhill Biopharma shares in Q1 2025, an estimated $2.46K.
  • Osaic Holdings first reported a position in Redhill Biopharma in Q1 2020 and held it in 19 quarters.
  • Osaic Holdings's Redhill Biopharma position peaked at $1.37M in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2025.

Based on Osaic Holdings's 13F filing for Q1 2025, filed 12 May 2025.